ARTICLE | Finance

Not slowing down

Biogen Idec says $100M cut doesn't mean less BD

October 27, 2014 7:00 AM UTC

The $100 million reduction by Biogen Idec Inc. (NASDAQ:BIIB) of guidance for business development spending for the remainder of the year does not reflect a change in strategy or appetite, according to EVP of Corporate Development Steven Holtzman. It simply reflects the fact that some deals Biogen expected to close this year now look like they'll mature in 1Q15.

"We are still as active as ever," Holtzman told BioCentury...